Investigation of the Synergic Effect of the Colistin/Sulbactam Combination in Carbapenem-Resistant Acinetobacter baumannii complex Strains with Time-Kill and Checkerboard Methods

被引:0
|
作者
Kilbas, Imdat [1 ]
Hatipoglu, Huseyin [1 ]
Kilic, Umit [1 ]
Kahraman Kilbas, Elmas Pinar [2 ]
Koroglu, Mehmet [1 ]
Altindis, Mustafa [1 ]
机构
[1] Sakarya Univ, Dept Med Microbiol, Fac Med, Sakarya, Turkey
[2] Fenerbahce Univ, Vocat Sch Hlth Serv, Dept Med Lab Tech, Istanbul, Turkey
来源
FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI | 2021年 / 26卷 / 01期
关键词
Acinetobacter baumannii; Colistin; Sulbactam; Synergy; Time-kill; Checkerboard; MULTIDRUG-RESISTANT; COLISTIN; SULBACTAM; MEROPENEM; EFFICACY; EPIDEMIOLOGY; MECHANISMS; IMIPENEM;
D O I
10.5578/flora.20219916
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Introduction: Infections caused by carbapenem-resistant Acinetobacter strains have become very common in recent years, and the most frequently used medicinal treatment is colistin. Combination treatments should also be applied to prevent development of resistance to colistin. This study examines the in vitro synergic effect of the colistin/sulbactam combination in carbapenem-resistant Acinetobacter strains with the time-kill and checkerboard methods. Materials and Methods: Twenty carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex strains, which were isolated from various clinical samples, were included in this study. Strains were identified with mass spectrometry, and antibiotic sensitivity results were determined with the VITEK 2 (R) system. The in vitro effect and synergic activity of the colistin, sulbactam, and colistin/sulbactam combination on the carbapenem-resistant strains were determined using the time-kill and checkerboard methods. Seventeen strains were examined with the time-kill method, and twenty strains were examined using the checkerboard method. The fractional inhibitory concentration index of strains was calculated for detection of synergic effect. Results: Using the time-kill method applied on the colistin/sulbactam combination showed that the combination had a synergic effect on all 17 strains, while sulbactam alone did not have a bactericidal effect in the studied concentrations. When applying the checkerboard method, it was determined that the colistin/sulbactam combination had a synergic effect on 17 of the strains (85%) and an additive effect on 3 strains (15%), sulbactam had a low effect alone (15%), and colistin was effective on all strains. Conclusion: Study results indicated that the colistin/sulbactam combination had a high level of synergic effect on all studied strains using both methods.
引用
收藏
页码:151 / 162
页数:12
相关论文
共 50 条
  • [31] The efficacy of colistin monotherapy versus combination therapy with other antimicrobials against carbapenem-resistant Acinetobacter baumannii ST2 isolates
    Li, Jiaying
    Fu, Yanjun
    Zhang, Jisheng
    Zhao, Yongxin
    Fan, Xuecai
    Yu, Lan
    Wang, Yong
    Zhang, Xiaoli
    Li, Chunjiang
    JOURNAL OF CHEMOTHERAPY, 2020, 32 (07) : 359 - 367
  • [32] In Vitro Synergistic Activity of Sulbactam in Combination with Imipenem, Meropenem and Cefoperazone Against Carbapenem-Resistant Acinetobacter baumannii Isolates
    Dagi, Hatice Turk
    Kus, Halit
    Arslan, Ugur
    Tuncer, Inci
    MIKROBIYOLOJI BULTENI, 2014, 48 (02): : 311 - 315
  • [33] Synergy Testing by Etest, Microdilution Checkerboard, and Time-Kill Methods for Pan-Drug-Resistant Acinetobacter baumannii
    Sopirala, Madhuri M.
    Mangino, Julie E.
    Gebreyes, Wondwossen A.
    Biller, Beth
    Bannerman, Tammy
    Balada-Llasat, Joan-Miquel
    Pancholi, Preeti
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (11) : 4678 - 4683
  • [34] Treatment of Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia: Retrospective Comparison Between Intravenous Colistin and Intravenous Ampicillin-Sulbactam
    Zalts, Ronen
    Neuberger, Ami
    Hussein, Khetam
    Raz-Pasteur, Ayelet
    Geffen, Yuval
    Mashiach, Tanya
    Finkelstein, Renato
    AMERICAN JOURNAL OF THERAPEUTICS, 2016, 23 (01) : E78 - E85
  • [35] In Vitro Activity of Minocycline Alone and in Combination with Cefoperazone-Sulbactam Against Carbapenem-Resistant Acinetobacter baumannii
    Pei, Guangsheng
    Mao, Yimin
    Sun, Yuxia
    MICROBIAL DRUG RESISTANCE, 2012, 18 (06) : 574 - 577
  • [36] Antimicrobial efficacy of doripenem and its combinations with sulbactam, amikacin, colistin, tigecycline in experimental sepsis of carbapenem-resistant Acinetobacter baumannii
    Dinc, Gokcen
    Demiraslan, Hayati
    Elmali, Ferhan
    Ahmed, Salman Shaheer
    Alp, Emine
    Doganay, Mehmet
    NEW MICROBIOLOGICA, 2015, 38 (01) : 67 - 73
  • [37] Successful treatment of skin and soft tissue infection due to carbapenem-resistant Acinetobacter baumannii by ampicillin-sulbactam and meropenem combination therapy
    Hiraki, Yoichi
    Yoshida, Mayumi
    Masuda, Yoko
    Inoue, Daisuke
    Tsuji, Yasuhiro
    Kamimura, Hidetoshi
    Karube, Yoshiharu
    Takaki, Kazutaka
    Kawano, Fumio
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2013, 17 (12) : E1234 - E1236
  • [38] Clinical Efficacy and Safety of the Combination of Colistin plus Vancomycin for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii
    Garnacho-Montero, Jose
    Amaya-Villar, Rosario
    Gutierrez-Pizarraya, Antonio
    Espejo-Gutierrez de Tena, Esther
    Luisa Artero-Gonzalez, M.
    Corcia-Palomo, Yael
    Bautista-Paloma, Javier
    CHEMOTHERAPY, 2013, 59 (03) : 225 - 231
  • [39] Implementation and evaluation of methods for the optimal detection of carbapenem-resistant and colistin-resistant Pseudomonas aeruginosa and Acinetobacter baumannii from stools
    Fournier, Claudine
    Poirel, Laurent
    Nordmann, Patrice
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2020, 98 (02)
  • [40] Time–kill effect of levofloxacin on multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: synergism with imipenem and colistin
    A. Safarika
    I. Galani
    A. Pistiki
    E. J. Giamarellos-Bourboulis
    European Journal of Clinical Microbiology & Infectious Diseases, 2015, 34 : 317 - 323